Skip to main content

1 Result(s)

within P. V. Brown Remove this filter

and

  1. No Access

    Article

    Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia

    Combined Fludarabine and Cyclophosphamide is now standard first-line therapy in chronic lymphocytic leukaemia (CLL) and the addition of Rituximab improves outcome.

    A. Hayat, S. McGuckin, E. Conneally, P. V. Brown… in Irish Journal of Medical Science (2009)